Table 3.
SHV-1 | Asn276Asp | |
---|---|---|
Clavulanate | ||
Ki(μM) | 1.37 ± 0.23 | 7.44 ± 0.84 |
KI(μM) | 0.72 ± 0.11 | 1.12 ± 0.11 |
kinact (s−1) | 0.015 ± 0.002 | 0.015 ± 0.002 |
kinact/KI (μM−1 s−1) | 0.021 ± 0.004 | 0.013 ± 0.002 |
kcat/kinact (tn) | 40 ± 10 | 50 ± 10 |
kcat (s−1) | 0.60 ± 0.17 | 0.75 ± 0.18 |
Achiral Cephalothin BATSI | ||
Ki(μM) | 42 ± 4 | 36 ± 4 |
Chiral Cephalothin BATSI | ||
Ki(μM) | 0.68 ± 0.07 | 3.8 ± 0.4 |
Methylidene Penem | ||
Ki(μM) | 0.057 ± 0.006 | 0.102 ± 0.001 |
Ki(μM) | 0.026 ± 0.004 | 0.039 ± 0.002 |
kinact (s−1) | 0.17 ± 0.01 | 0.24 ± 0.02 |
kinact/KI (μM−1 s−1) | 6.5 ± 1.0 | 6.2 ± 0.6 |
kcat/kinact (tn) | 2 ± 1 | 2 ± 1 |
kcat (s−1) | 0.34 ± 0.17 | 0.48 ± 0.24 |
Meropenem | ||
Ki(μM) | 31 ± 3 | 1411 ± 14 |